{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:08:30Z","timestamp":1791317310530,"version":"4.3.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31797-2","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T22:14:24Z","timestamp":1766873664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Associations between peripheral neuropathy and cardiovascular complications in patients with type 2 diabetes mellitus: a cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4342-0564","authenticated-orcid":false,"given":"Marzieh","family":"Poorrezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-391X","authenticated-orcid":false,"given":"Mohammad Ali","family":"Zakeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6670-1828","authenticated-orcid":false,"given":"Zahra","family":"Kamiab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9318-2904","authenticated-orcid":false,"given":"Mohammadreza","family":"Shafiepour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-934X","authenticated-orcid":false,"given":"Parvin","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-7269","authenticated-orcid":false,"given":"Alaa Hamza","family":"Hermis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim K.","family":"Hajwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8420-9669","authenticated-orcid":false,"given":"Inshal","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-6219","authenticated-orcid":false,"given":"Maryam","family":"Karimifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"issue":"6","key":"31797_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/jpm12060905","volume":"12","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Predicting the risk of incident type 2 diabetes mellitus in Chinese elderly using machine learning techniques. J. Personalized Med. 12 (6), 905 (2022).","journal-title":"J. Personalized Med."},{"key":"31797_CR2","doi-asserted-by":"publisher","first-page":"p108086","DOI":"10.1016\/j.diabres.2020.108086","volume":"162","author":"P Saeedi","year":"2020","unstructured":"Saeedi, P. et al. Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas. Diabetes Res. Clin. Pract. 162, p108086 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"31797_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1515\/jpem-2021-0271","volume":"35","author":"\u0130 D\u00fcndar","year":"2022","unstructured":"D\u00fcndar, \u0130. & Ak\u0131nc\u0131, A. Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children. J. Pediatr. Endocrinol. Metab. 35 (4), 435\u2013441 (2022).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"31797_CR4","doi-asserted-by":"crossref","unstructured":"Davies, J. L. et al. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: mid North American Ethnic Cohort Survey. Muscle Nerve 1, 1 (2023).","DOI":"10.1002\/mus.27793"},{"key":"31797_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1150-5","volume":"19","author":"P Shillo","year":"2019","unstructured":"Shillo, P. et al. Painful and painless diabetic neuropathies: what is the difference? Curr. Diab. Rep. 19, 1\u201313 (2019).","journal-title":"Curr. Diab. Rep."},{"issue":"6","key":"31797_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman, E. L. et al. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93 (6), 1296\u20131313 (2017).","journal-title":"Neuron"},{"key":"31797_CR7","doi-asserted-by":"crossref","unstructured":"Thaisetthawatkul, P. & Dyck, P. J. B. Asymmetric diabetic neuropathy: radiculoplexus neuropathies, mononeuropathies, and cranial neuropathies. In Diabetic Neuropathy: Advances in Pathophysiology and Clinical Management 165\u2013181 (Springer, 2023).","DOI":"10.1007\/978-3-031-15613-7_10"},{"issue":"1","key":"31797_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10122","volume":"22","author":"A Bondar","year":"2021","unstructured":"Bondar, A. et al. Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options. Experimental Therapeutic Med. 22 (1), 1\u20139 (2021).","journal-title":"Experimental Therapeutic Med."},{"issue":"1","key":"31797_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1574886315666200731173113","volume":"16","author":"J R\u00f8ikjer","year":"2021","unstructured":"R\u00f8ikjer, J. & Ejskjaer, N. Diabetic peripheral neuropathy: diagnosis and treatment. Curr. Drug Saf. 16 (1), 2\u201316 (2021).","journal-title":"Curr. Drug Saf."},{"issue":"4","key":"31797_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/diacare.1.4.252","volume":"1","author":"J Pirart","year":"1978","unstructured":"Pirart, J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1 (4), 252\u2013263 (1978).","journal-title":"Diabetes Care"},{"key":"31797_CR11","first-page":"10104","volume":"1","author":"OT Chukwubuzo","year":"2022","unstructured":"Chukwubuzo, O. T. et al. Prevalence and associations of neuropathic pain among subjects with diabetes mellitus in the Enugu diabetic peripheral neuropathy (Edipen) study. J. Pharm. Negat. Results. 1, 10104\u201310117 (2022).","journal-title":"J. Pharm. Negat. Results"},{"issue":"01","key":"31797_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/ijmbs.ijmbs_3_19","volume":"11","author":"A Elbarsha","year":"2019","unstructured":"Elbarsha, A., Hamedh, M. & Elsaeiti, M. Prevalence and risk factors of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Ibnosina J. Med. Biomedical Sci. 11 (01), 25\u201328 (2019).","journal-title":"Ibnosina J. Med. Biomedical Sci."},{"issue":"2","key":"31797_CR13","first-page":"153","volume":"14","author":"J Quiroz-Aldave","year":"2023","unstructured":"Quiroz-Aldave, J. et al. Diabetic neuropathy: Past, present, and future. Caspian J. Intern. Med. 14 (2), 153 (2023).","journal-title":"Caspian J. Intern. Med."},{"issue":"8","key":"31797_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cardfail.2019.05.007","volume":"25","author":"SM Dunlay","year":"2019","unstructured":"Dunlay, S. M. et al. Type 2 diabetes mellitus and heart failure, a scientific statement from the American heart association and heart failure society of America. J. Card. Fail. 25 (8), 584\u2013619 (2019).","journal-title":"J. Card. Fail."},{"issue":"8","key":"31797_CR15","first-page":"1","volume":"15","author":"F Jyotsna","year":"2023","unstructured":"Jyotsna, F. et al. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus 15 (8), 1 (2023).","journal-title":"Cureus"},{"issue":"39","key":"31797_CR16","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx, N. et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European society of cardiology (ESC). Eur. Heart J. 44 (39), 4043\u20134140 (2023).","journal-title":"Eur. Heart J."},{"issue":"7","key":"31797_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani, A. et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 379 (7), 633\u2013644 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"31797_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","volume":"14","author":"PV Dludla","year":"2023","unstructured":"Dludla, P. V. et al. Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress. World J. Diabetes. 14 (3), 130 (2023).","journal-title":"World J. Diabetes"},{"issue":"7","key":"31797_CR19","doi-asserted-by":"publisher","first-page":"e0306482","DOI":"10.1371\/journal.pone.0306482","volume":"19","author":"A Pet\u0151","year":"2024","unstructured":"Pet\u0151, A. et al. Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary. PLoS ONE. 19 (7), e0306482 (2024).","journal-title":"PLoS ONE"},{"key":"31797_CR20","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1007\/s12325-016-0399-1","volume":"33","author":"D Baltzis","year":"2016","unstructured":"Baltzis, D. et al. Diabetic peripheral neuropathy as a predictor of asymptomatic myocardial ischemia in type 2 diabetes mellitus: a cross-sectional study. Adv. Therapy. 33, 1840\u20131847 (2016).","journal-title":"Adv. Therapy"},{"key":"31797_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/DMSO.S352316","volume":"1","author":"L Li","year":"2022","unstructured":"Li, L. et al. Impaired vascular endothelial function is associated with peripheral neuropathy in patients with type 2 diabetes. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 1, 1437\u20131449 (2022).","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"issue":"4","key":"31797_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/1474515114565215","volume":"15","author":"J Ybarra-Mu\u00f1oz","year":"2016","unstructured":"Ybarra-Mu\u00f1oz, J. et al. Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study. Eur. J. Cardiovasc. Nurs. 15 (4), 248\u2013254 (2016).","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"31797_CR23","unstructured":"ElSayed, N. A. et al. Introduction and methodology: standards of care in diabetes\u20142023. Am. Diabetes Assoc. 1, S1\u2013S4 (2023)."},{"key":"31797_CR24","doi-asserted-by":"crossref","unstructured":"Viswanathan, V. et al. Precision of Michigan neuropathy screening instrument (MNSI) tool for the diagnosis of diabetic peripheral neuropathy among people with type 2 diabetes\u2014a study from South India. Int. J. Low. Extrem. Wounds 15347346231163209 (2023).","DOI":"10.1177\/15347346231163209"},{"issue":"7","key":"31797_CR25","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/dc21-0010","volume":"44","author":"L Bjerg","year":"2021","unstructured":"Bjerg, L. et al. Diabetic polyneuropathy early in type 2 diabetes is associated with higher incidence rate of cardiovascular disease: results from two Danish cohort studies. Diabetes Care. 44 (7), 1714\u20131721 (2021).","journal-title":"Diabetes Care"},{"key":"31797_CR26","doi-asserted-by":"crossref","unstructured":"Khawaja, N. et al. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol. Metab. Syndr. 10, 8 (2018).","DOI":"10.1186\/s13098-018-0309-6"},{"issue":"8","key":"31797_CR27","doi-asserted-by":"publisher","first-page":"e3702","DOI":"10.1002\/dmrr.3702","volume":"39","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Prevalence and risk factors of diabetic peripheral neuropathy: a population-based cross\u2010sectional study in China. Diab.\/Metab. Res. Rev. 39 (8), e3702 (2023).","journal-title":"Diab.\/Metab. Res. Rev."},{"issue":"23","key":"31797_CR28","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","volume":"100","author":"JR Brownrigg","year":"2014","unstructured":"Brownrigg, J. R. et al. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus. Heart 100 (23), 1837\u20131843 (2014).","journal-title":"Heart"},{"issue":"11","key":"31797_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/jdi.14063","volume":"14","author":"K Kim","year":"2023","unstructured":"Kim, K. et al. Associations of polyneuropathy with risk of all-cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status. J. Diabetes Invest. 14 (11), 1279\u20131288 (2023).","journal-title":"J. Diabetes Invest."},{"issue":"4","key":"31797_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4093\/dmj.2011.35.4.390","volume":"35","author":"JO Chung","year":"2011","unstructured":"Chung, J. O. et al. Association between diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients. Diabetes Metabolism J. 35 (4), 390 (2011).","journal-title":"Diabetes Metabolism J."},{"issue":"12","key":"31797_CR31","first-page":"1","volume":"12","author":"G AlGhamdi","year":"2020","unstructured":"AlGhamdi, G. et al. Peripheral neuropathy as a risk factor for developing cardiovascular disease in diabetic patients. Cureus 12 (12), 1 (2020).","journal-title":"Cureus"},{"issue":"2","key":"31797_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2337\/dc08-1250","volume":"32","author":"L Karvestedt","year":"2009","unstructured":"Karvestedt, L. et al. Peripheral sensory neuropathy associates with micro-or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care. 32 (2), 317\u2013322 (2009).","journal-title":"Diabetes Care"},{"key":"31797_CR33","first-page":"1","volume":"1","author":"J Brownrigg","year":"2013","unstructured":"Brownrigg, J. et al. Peripheral neuropathy is an independent predictor of cardiovascular events among individuals with diabetes mellitus. Am. Heart Assoc. 1, 1 (2013).","journal-title":"Am. Heart Assoc."},{"issue":"1","key":"31797_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12944-023-02001-z","volume":"23","author":"CS Kuo","year":"2024","unstructured":"Kuo, C. S. et al. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan diabetes registry study. Lipids Health Dis. 23 (1), 24 (2024).","journal-title":"Lipids Health Dis."},{"issue":"12","key":"31797_CR35","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.2337\/db07-0740","volume":"56","author":"AP Kellogg","year":"2007","unstructured":"Kellogg, A. P. et al. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56 (12), 2997\u20133005 (2007).","journal-title":"Diabetes"},{"issue":"6","key":"31797_CR36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/acn3.51367","volume":"8","author":"AE Rumora","year":"2021","unstructured":"Rumora, A. E. et al. Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes. Ann. Clin. Transl. Neurol. 8 (6), 1292\u20131307 (2021).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"23","key":"31797_CR37","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.3390\/ijms21239005","volume":"21","author":"NMZ Bakkar","year":"2020","unstructured":"Bakkar, N. M. Z. et al. Cardiac autonomic neuropathy: a progressive consequence of chronic low-grade inflammation in type 2 diabetes and related metabolic disorders. Int. J. Mol. Sci. 21 (23), 9005 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"31797_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1900\/RDS.2022.18.20","volume":"18","author":"E Yunir","year":"2022","unstructured":"Yunir, E. et al. Factors affecting mortality of critical limb ischemia 1 year after endovascular revascularization in patients with type 2 diabetes mellitus. Rev. Diabet. Stud. 18 (1), 20 (2022).","journal-title":"Rev. Diabet. Stud."},{"issue":"1","key":"31797_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jdi.12042","volume":"4","author":"AI Vinik","year":"2013","unstructured":"Vinik, A. I., Erbas, T. & Casellini, C. M. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J. Diabetes Invest. 4 (1), 4\u201318 (2013).","journal-title":"J. Diabetes Invest."},{"key":"31797_CR40","doi-asserted-by":"publisher","first-page":"110762","DOI":"10.1016\/j.diabres.2023.110762","volume":"206","author":"R Pop-Busui","year":"2023","unstructured":"Pop-Busui, R. Autonomic diabetic neuropathies: a brief overview. Diabetes Res. Clin. Pract. 206, 110762 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"12","key":"31797_CR41","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.3390\/biomedicines10123258","volume":"10","author":"SZ Sudo","year":"2022","unstructured":"Sudo, S. Z. et al. Diabetes-induced cardiac autonomic neuropathy: impact on heart function and prognosis. Biomedicines 10 (12), 3258 (2022).","journal-title":"Biomedicines"},{"key":"31797_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fnins.2018.00591","volume":"12","author":"AI Vinik","year":"2018","unstructured":"Vinik, A. I. et al. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front. NeuroSci. 12, 591 (2018).","journal-title":"Front. NeuroSci."},{"issue":"3","key":"31797_CR43","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/ehf2.12669","volume":"7","author":"IR Mordi","year":"2020","unstructured":"Mordi, I. R. et al. Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes. ESC Heart Fail. 7 (3), 1168\u20131177 (2020).","journal-title":"ESC Heart Fail."},{"key":"31797_CR44","unstructured":"Polemiti, E. Identifying Risk of Microvascular and Macrovascular Complications of Type 2 Diabetes: Findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study (Universit\u00e4t Potsdam, 2022)."},{"issue":"1","key":"31797_CR45","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1038\/s41598-024-55556-x","volume":"14","author":"WB Shillah","year":"2024","unstructured":"Shillah, W. B. et al. Predictors of microvascular complications in patients with type 2 diabetes mellitus at regional referral hospitals in the central zone, tanzania: a cross-sectional study. Sci. Rep. 14 (1), 5035 (2024).","journal-title":"Sci. Rep."},{"key":"31797_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ahj.2021.10.181","volume":"243","author":"SV Arnold","year":"2022","unstructured":"Arnold, S. V. et al. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study. Am. Heart J. 243, 232\u2013239 (2022).","journal-title":"Am. Heart J."},{"issue":"1","key":"31797_CR47","doi-asserted-by":"publisher","first-page":"15245","DOI":"10.1038\/s41598-021-94121-8","volume":"11","author":"MA Salinero-Fort","year":"2021","unstructured":"Salinero-Fort, M. A. et al. Cardiovascular risk factors associated with acute myocardial infarction and stroke in the MADIABETES cohort. Sci. Rep. 11 (1), 15245 (2021).","journal-title":"Sci. Rep."},{"issue":"6","key":"31797_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jdiacomp.2017.03.007","volume":"31","author":"R Unnikrishnan","year":"2017","unstructured":"Unnikrishnan, R. et al. Younger-onset versus older-onset type 2 diabetes: clinical profile and complications. J. Diabetes Complicat. 31 (6), 971\u2013975 (2017).","journal-title":"J. Diabetes Complicat."},{"issue":"3","key":"31797_CR49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jdiacomp.2017.11.009","volume":"32","author":"N Nanayakkara","year":"2018","unstructured":"Nanayakkara, N. et al. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. J. Diabetes Complicat. 32 (3), 279\u2013290 (2018).","journal-title":"J. Diabetes Complicat."},{"key":"31797_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00125-020-05319-w","volume":"64","author":"N Nanayakkara","year":"2021","unstructured":"Nanayakkara, N. et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 64, 275\u2013287 (2021).","journal-title":"Diabetologia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31797-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:05:42Z","timestamp":1768485942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31797"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31797-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of Rafsanjan University of Medical Sciences, with the code of ethics No. IR.RUMS.REC.1403.011. All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all participants before participating in this study. All participants agreed to be included in the study anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"2129"}}